bf/NASDAQ:AUPH_icon.png

COM:AURINIAPHARMA

Aurinia Pharmaceuticals Inc.

  • Stock

Last Close

8.77

22/11 14:59

Market Cap

1.26B

Beta: -

Volume Today

408.45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-54.50K
-
-54.50K
0%
6.96M
-
16.63M
138.77%
22.04M
32.55%
32.23M
46.23%
average payables
1.13M
-
1.25M
10.00%
1.74M
39.04%
2.47M
42.38%
3.32M
34.28%
5.42M
63.41%
5.61M
3.50%
3.39M
39.52%
3.26M
4.04%
3.48M
6.94%
3.71M
6.43%
average receivables
145.04K
-
99.06K
31.70%
69.50K
29.84%
66.50K
4.32%
97.50K
46.62%
163K
67.18%
292.50K
79.45%
693K
136.92%
8.22M
1,085.57%
14.45M
75.86%
18.79M
30.02%
book value per share
2.10
-
1.55
26.21%
0.62
59.87%
1.02
64.10%
2.15
111.41%
1.33
38.35%
2.94
121.44%
3.44
17.05%
3.70
7.60%
2.86
22.86%
2.64
7.64%
capex per share
-0.02
-
-0.00
81.22%
-0.00
49.62%
-0.00
54.44%
-0.00
54.14%
-0.00
172.28%
-0.00
26.38%
-0.06
5,443.91%
-0.01
81.28%
-0.00
82.27%
-0.01
143.62%
capex to depreciation
-0.13
-
-0.06
53.84%
-0.03
45.76%
-0.02
47.33%
-0.02
1.58%
-0.05
179.11%
-0.07
40.19%
-5.36
7,872.12%
-0.54
89.85%
-0.11
80.15%
-0.06
42.87%
capex to operating cash flow
0.02
-
0.01
76.90%
0.00
47.14%
0.00
52.53%
0.00
54.55%
0.00
139.31%
0.00
12.78%
0.11
6,313.52%
0.01
90.94%
0.00
61.43%
0.02
484.42%
capex to revenue
-0.11
-
-0.32
194.58%
-0.21
34.28%
-0.14
32.08%
-0.06
58.81%
-0.16
172.14%
-0.33
101.90%
-0.15
55.20%
-0.03
77.54%
-0.00
93.38%
-0.00
87.77%
cash per share
0.29
-
1.12
291.14%
0.49
56.32%
1.12
129.36%
2.25
100.62%
1.48
34.15%
3.29
121.61%
3.36
2.20%
3.60
7.15%
2.74
23.84%
2.45
10.82%
days of inventory on hand
-39.78K
-
101.01
-
6.47K
6,301.19%
1.60K
75.33%
1.02K
35.78%
days payables outstanding
429.24K
-
13.73K
96.80%
63.24K
360.51%
261.25K
313.13%
1.38M
427.14%
62.37
100.00%
28.67
54.03%
19.11
33.35%
1.30K
6,690.71%
198.93
84.67%
111.63
43.89%
days sales outstanding
40.84
-
120.79
195.79%
73
39.57%
181.45
148.55%
94.73
47.79%
171.07
80.59%
422.39
146.91%
7.41
98.24%
123.37
1,563.98%
36.72
70.24%
50.10
36.43%
debt to assets
0.13
-
0.05
-
0.02
58.29%
-0.00
103.78%
0.02
2,713.14%
0.02
14.23%
0.02
11.30%
0.02
6.80%
0.18
936.82%
debt to equity
0.23
-
0.08
-
0.02
69.86%
-0.00
104.27%
0.03
2,508.82%
0.02
18.34%
0.02
11.53%
0.02
9.36%
0.26
1,194.56%
dividend yield
earnings yield
-0.10
-
-0.16
52.42%
-0.23
49.37%
-0.31
34.19%
-0.19
39.66%
-0.11
41.54%
-0.07
40.74%
-0.06
4.63%
-0.06
2.40%
-0.18
188.49%
-0.06
65.66%
enterprise value
22.92M
-
83.43M
263.96%
73.66M
11.70%
34.45M
53.23%
207.57M
502.53%
460.25M
121.73%
1.58B
243.00%
1.37B
12.93%
2.74B
99.01%
526.99M
80.74%
1.34B
153.60%
enterprise value over ebitda
-7.13
-
-5.32
25.45%
-2.73
48.57%
-1.65
39.50%
-9.57
478.74%
-10.31
7.70%
-19.49
89.05%
-14.29
26.69%
-15.31
7.16%
-4.73
69.13%
-18.65
294.45%
ev to operating cash flow
-5.07
-
-4.94
2.61%
-4.15
15.99%
-1.84
55.60%
-5.04
173.87%
-8.92
76.87%
-24.88
178.97%
-19.68
20.91%
-17.35
11.84%
-6.63
61.80%
-39.94
502.74%
ev to sales
24.17
-
300.10
1,141.87%
313.47
4.45%
199.13
36.47%
494.21
148.18%
994.05
101.14%
4.96K
399.40%
27.43
99.45%
59.98
118.71%
3.93
93.44%
7.61
93.66%
free cash flow per share
-0.73
-
-0.58
20.09%
-0.55
4.93%
-0.53
4.16%
-0.54
0.81%
-0.61
13.87%
-0.68
12.08%
-0.65
4.63%
-1.23
88.84%
-0.56
54.29%
-0.24
57.58%
free cash flow yield
-0.19
-
-0.16
14.39%
-0.22
40.10%
-0.25
12.73%
-0.11
56.35%
-0.09
19.02%
-0.03
62.27%
-0.05
39.71%
-0.05
14.19%
-0.13
141.98%
-0.03
79.61%
graham net net
-1.25
-
0.87
169.85%
0.07
92.23%
0.53
678.76%
1.94
266.98%
1.09
43.66%
2.72
148.79%
2.96
8.61%
3.27
10.64%
2.44
25.34%
1.52
37.57%
graham number
4.35
-
4.46
2.45%
2.84
36.22%
3.89
36.83%
6.68
71.64%
4.75
28.81%
9.38
97.43%
8.19
12.71%
10.80
31.78%
7.00
35.16%
5.69
18.76%
income quality
1.78
-
1.02
42.84%
0.95
5.97%
0.80
15.87%
0.58
27.61%
0.80
38.41%
0.51
36.34%
0.68
32.78%
0.87
28.08%
0.74
15.63%
0.43
41.66%
intangibles to total assets
0.90
-
0.35
60.84%
0.51
43.45%
0.27
46.12%
0.07
72.75%
0.09
16.32%
0.03
60.21%
0.02
41.52%
0.02
23.15%
0.01
11.78%
0.01
33.45%
interest coverage
-54.79
-
-576.07
951.50%
-471.60
18.13%
-844.96
79.17%
-67.04
92.07%
-25.14
62.50%
-2.12K
8,319.11%
-21.78
-
-30.02
37.84%
interest debt per share
0.51
-
0.00
99.80%
0.00
51.14%
0.08
5,285.58%
0.06
25.98%
0.02
59.74%
0.07
199.13%
0.07
4.95%
0.07
4.81%
0.09
37.76%
0.70
653.11%
inventory turnover
-0.01
-
3.61
-
0.06
98.44%
0.23
305.35%
0.36
55.72%
invested capital
0.23
-
0.08
-
0.02
69.86%
-0.00
104.27%
0.03
2,508.82%
0.02
18.34%
0.02
11.53%
0.02
9.36%
0.26
1,194.56%
market cap
24.74M
-
106.14M
328.97%
79.42M
25.17%
74.10M
6.70%
373.20M
403.65%
578.21M
54.94%
1.88B
225.95%
1.64B
13.06%
2.96B
80.57%
613.07M
79.28%
1.29B
110.04%
net current asset value
-7.75M
-
26.28M
439.21%
2.93M
88.85%
20.37M
595.26%
151.15M
641.98%
99.56M
34.13%
261.97M
163.13%
363.52M
38.76%
449.05M
23.53%
377.11M
16.02%
254.69M
32.46%
net debt to ebitda
0.57
-
1.45
155.64%
0.21
85.23%
1.90
791.17%
7.64
301.25%
2.64
65.40%
3.78
42.98%
2.74
27.38%
1.25
54.47%
0.77
38.18%
-0.68
188.05%
net income per share
-0.40
-
-0.57
42.26%
-0.58
1.36%
-0.66
14.09%
-0.92
39.35%
-0.76
17.79%
-1.33
76.03%
-0.87
34.90%
-1.40
61.40%
-0.76
45.51%
-0.54
28.54%
operating cash flow per share
-0.71
-
-0.58
18.69%
-0.55
4.69%
-0.53
4.02%
-0.54
0.88%
-0.61
13.78%
-0.68
12.06%
-0.59
13.56%
-1.22
106.72%
-0.56
54.03%
-0.23
58.31%
payables turnover
0.00
-
0.03
3,025.86%
0.01
78.28%
0.00
75.79%
0.00
81.03%
5.85
2,207,993.42%
12.73
117.51%
19.10
50.04%
0.28
98.53%
1.83
552.35%
3.27
78.21%
receivables turnover
8.94
-
3.02
66.19%
5
65.47%
2.01
59.77%
3.85
91.55%
2.13
44.63%
0.86
59.50%
49.23
5,597.27%
2.96
93.99%
9.94
235.98%
7.29
26.70%
research and ddevelopement to revenue
2.04
-
32.78
1,507.81%
68.01
107.49%
84.01
23.53%
80.79
3.84%
89.38
10.64%
166.25
86.00%
1.00
99.40%
1.12
11.67%
0.34
70.07%
0.28
15.74%
return on tangible assets
-1.12
-
-0.49
55.95%
-1.12
128.60%
-0.56
49.95%
-0.40
28.33%
-0.48
19.45%
-0.39
18.41%
-0.23
42.44%
-0.34
49.68%
-0.23
31.14%
-0.14
38.32%
revenue per share
0.15
-
0.01
93.62%
0.01
23.34%
0.00
32.92%
0.01
11.33%
0.01
0.05%
0.00
37.40%
0.42
12,274.92%
0.35
16.67%
0.94
167.91%
1.23
29.74%
roe
-0.19
-
-0.37
92.80%
-0.93
152.55%
-0.65
30.48%
-0.43
34.08%
-0.57
33.35%
-0.45
20.50%
-0.25
44.38%
-0.38
50.00%
-0.27
29.36%
-0.21
22.64%
roic
-0.13
-
-0.38
187.72%
-0.87
125.49%
-0.60
30.80%
-0.37
38.09%
-0.50
34.82%
-0.29
41.06%
-0.25
16.72%
-0.37
48.93%
-0.27
26.42%
-0.15
44.05%
sales general and administrative to revenue
2.35
-
24.78
953.54%
26.65
7.53%
40.29
51.17%
28.80
28.52%
29.53
2.55%
69.67
135.89%
1.92
97.25%
3.76
96.29%
1.47
61.03%
1.11
24.15%
shareholders equity per share
2.10
-
1.55
26.21%
0.62
59.87%
1.02
64.10%
2.15
111.41%
1.33
38.35%
2.94
121.44%
3.44
17.05%
3.70
7.60%
2.86
22.86%
2.64
7.64%
stock based compensation to revenue
0.24
-
7.86
3,236.95%
13.72
74.47%
7.99
41.73%
10.10
26.34%
14.82
46.70%
23.31
57.36%
0.35
98.51%
0.69
96.72%
0.24
64.82%
0.26
7.13%
tangible asset value
-7.56M
-
26.62M
452.15%
2.97M
88.86%
20.40M
587.80%
151.63M
643.27%
99.96M
34.08%
262.27M
162.38%
398.42M
51.91%
470.69M
18.14%
399.01M
15.23%
372.98M
6.52%
tangible book value per share
-1.19
-
0.91
176.62%
0.09
89.90%
0.58
526.76%
1.97
240.83%
1.18
40.17%
2.82
139.13%
3.36
19.28%
3.64
8.19%
2.81
22.72%
2.60
7.39%
working capital
-3.95M
-
30.71M
878.12%
12.92M
57.95%
33.49M
159.26%
167.10M
398.99%
125.59M
24.84%
303.84M
141.94%
387.43M
27.51%
472.68M
22.00%
396.43M
16.13%
347.61M
12.31%

All numbers in (except ratios and percentages)